1998 Multiple Myeloma Update: New Insights and Future DirectionsANDERSON, Kenneth.Seminars in oncology. 1999, Vol 26, Num 5, issn 0093-7754, 43 p., SUP13Serial Issue

Preclinical Studies of Novel Targeted TherapiesHIDESHIMA, Teru; ANDERSON, Kenneth C.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, viii-ix, 1071-1091 [22 p.]Article

Structural computing requirements for the transformation of structures and behaviorsANDERSON, Kenneth M.Lecture notes in computer science. 2000, Vol 1903, pp 140-146, issn 0302-9743, isbn 3-540-41084-8Conference Paper

Introduction to SC2ANDERSON, Kenneth M.Lecture notes in computer science. 2000, Vol 1903, pp 96-97, issn 0302-9743, isbn 3-540-41084-8Conference Paper

The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple MyelomaANDERSON, Kenneth C.Journal of clinical oncology. 2012, Vol 30, Num 4, pp 445-452, issn 0732-183X, 8 p.Article

New approaches to the treatment of multiple myelomaANDERSON, Kenneth C.Seminars in oncology. 2001, Vol 28, Num 6, issn 0093-7754, 100 p.Serial Issue

Thalidomide Therapy for Hematologic MalignanciesANDERSON, Kenneth C.Seminars in hematology. 2000, Vol 37, Num 1, issn 0037-1963, 41 p., SUP3Serial Issue

Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment : Multiple MyelomaANDERSON, Kenneth C.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1225-1233, issn 1078-0432, 9 p.Article

Multiple myelomaANDERSON, Kenneth C.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, 315 p.Serial Issue

The clinical potential of proteasome inhibitionANDERSON, Kenneth C.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 6, pp 3-6, issn 1359-6349, 4 p.Conference Paper

Lenalidomide and thalidomide : Mechanisms of action-similarities and differencesANDERSON, Kenneth C.Seminars in hematology. 2005, Vol 42, Num 4, pp S3-S8, issn 0037-1963, SUP4Article

The extensibility mechanisms of the Chimera open hypermedia systemANDERSON, Kenneth M.Journal of network and computer applications. 2001, Vol 24, Num 1, pp 75-86, issn 1084-8045Article

Drug resistance in multiple myeloma : Approaches to circumventionDALTON, W. S; JOVE, R.Seminars in oncology. 1999, Vol 26, Num 5, pp 23-27, issn 0093-7754, SUP13Article

Moving Toward Individualized Cancer TherapiesTONON, Giovanni; ANDERSON, Kenneth C.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4682-4684, issn 1078-0432, 3 p.Article

Molecular Pathogenesis of Multiple MyelomaTONON, Giovanni.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, vii, 985-1006 [21 p.]Article

Trunk muscle activity increases with unstable squat movementsANDERSON, Kenneth; BEHM, David G.Canadian journal of applied physiology. 2005, Vol 30, Num 1, pp 33-45, issn 1066-7814, 13 p.Article

Histone deacetylase inhibitors in the treatment for multiple myeloma : PIH: Basic and Clinical Updates in Multiple MyelomaHIDESHIMA, Teru; ANDERSON, Kenneth C.International journal of hematology. 2013, Vol 97, Num 3, pp 324-332, issn 0925-5710, 9 p.Article

Multiple MyelomaPALUMBO, Antonio; ANDERSON, Kenneth.The New England journal of medicine. 2011, Vol 364, Num 11, pp 1046-1060, issn 0028-4793, 15 p.Article

Synopsis of a roundtable on validating novel therapeutics for multiple myelomaDALTON, William; ANDERSON, Kenneth C.Clinical cancer research. 2006, Vol 12, Num 22, pp 6603-6610, issn 1078-0432, 8 p.Article

Targeted therapy for multiple myelomaANDERSON, Kenneth C.Seminars in hematology. 2001, Vol 38, Num 3, pp 286-294, issn 0037-1963Article

Maintenance therapy and supportive care for patients with multiple myelomaKYLE, R. A.Seminars in oncology. 1999, Vol 26, Num 5, pp 35-42, issn 0093-7754, SUP13Article

Novel therapies in MM: from the aspect of preclinical studies : PIH: Understanding the Pathogenesis and the Evolving Treatment Paradigm for Multiple Myeloma in the Era of Novel AgentsHIDESHIMA, Teru; ANDERSON, Kenneth C.International journal of hematology. 2011, Vol 94, Num 4, pp 344-354, issn 0925-5710, 11 p.Article

Complications of Myeloma TherapyDISPENZIERI, Angela.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, xi, 1247-1273 [28 p.]Article

The impact of instability resistance training on balance and stabilityANDERSON, Kenneth; BEHM, David G.Sports medicine (Auckland). 2005, Vol 35, Num 1, pp 43-53, issn 0112-1642, 11 p.Article

The role of immunomodulatory drugs in multiple myelomaANDERSON, Kenneth C.Seminars in hematology. 2003, Vol 40, Num 4, pp 23-32, issn 0037-1963, 10 p., SUP4Conference Paper